Skip to main content

Table 3 Analysis of the 5-year overall survival rates of patients using the 8th AJCC pN classification stratified into Limited (< 16 eLNs) and Adequate (≥ 16 eLNs) eLN cohorts

From: A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes

Nodal classification

Limited eLN cohort

Adequate eLN cohort

P value (Limited vs. Adequate eLN cohort)

Combined eLN cohort

Number [cases (%)]

5-year OS (%)

Number [cases (%)]

5-year OS (%)

Number [cases (%)]

5-year OS (%)

8th AJCC pN

 N0

271 (34.1)

76.4

382 (25.3)

87.5

< 0.001

653 (28.3)

82.7

 N1

207 (26.1)

57.1

227 (15.0)

73.4

< 0.001

434 (18.8)

65.2

 N2

209 (26.3)

36.3

282 (18.7)

60.8

< 0.001

491 (21.3)

49.4

 N3a

107 (13.5)

19.2

382 (25.3)

43.0

< 0.001

489 (21.2)

37.8

 N3b

  

237 (15.7)

24.8

 

237 (10.3)

24.8

pN′

 N′0

  

382 (25.3)

87.5

 

382 (16.6)

87.5

 N′1

271 (34.1)

76.4

227 (15.0)

73.4

0.853

498 (21.6)

75.1

 N′2

207 (26.1)

57.1

282 (18.7)

60.8

0.476

489 (21.2)

59.1

 N′3a

209 (26.3)

36.3

382 (25.3)

43.0

0.114

591 (25.7)

40.4

 N′3b

107 (13.5)

19.2

237 (15.7)

24.8

0.230

344 (14.9)

23.1

8th AJCC pTNM

 IB

57 (7.2)

91.6

105 (7.0)

96.9

0.136

162 (7.0)

94.8

 IIA

81 (10.2)

78.5

121 (8.0)

90.4

0.169

202 (8.8)

85.3

 IIB

195 (24.6)

72.4

281 (18.6)

77.7

0.038

476 (20.7)

75.5

 IIIA

305 (38.4)

42.9

369 (24.4)

66.1

< 0.001

674 (29.3)

54.7

 IIIB

137 (17.3)

25.4

364 (24.1)

43.9

< 0.001

501 (21.7)

38.8

 IIIC

19 (2.4)

8.4

270 (17.9)

24.3

0.016

289 (12.5)

23.2

pTN′M

 IB′

  

105 (7.0)

96.9

 

105 (4.6)

96.9

 IIA′

57 (7.2)

91.6

121 (8.0)

90.4

0.677

178 (7.7)

90.7

 IIB′

81 (10.2)

78.5

281 (18.6)

77.7

0.995

362 (15.7)

77.8

 IIIA′

316 (39.8)

63.1

369 (24.4)

66.1

0.325

685 (29.7)

64.6

 IIIB′

205 (25.8)

39.3

364 (24.1)

43.9

0.197

569 (24.7)

42.2

 IIIC′

135 (17.0)

18.8

270 (17.9)

24.3

0.218

405 (17.6)

22.4

  1. eLNs pathologically examined lymph nodes, OS overall survival rate, AJCC American Joint Committee on Cancer, pN pathologically examined nodal classification, N′ pathologically examined modified nodal classification, pTNM pathological tumor-node-metastasis classification, TN′M pathological tumor-modified node-metastasis classification